|
|
Chinese clinical practice guidelines for ultrasound-guided irreversible electroporation of liver cancer (version 2022) |
Min Xu a , b , Li-Ting Xie a , b , Yue-Yong Xiao c , Ping Liang d , Qi-Yu Zhao a , b , Zhong-Min Wang e , Wei-Lu Chai a , b , Ying-Tian Wei c , Lin-Feng Xu f , Xiao-Kun Hu g , Ming Kuang h , Li-Zhi Niu i , Chen-Guo Yao j , Hai-Ying Kong k , Guo Tian a , b , Xiao-Yan Xie l , Xin-Wu Cui m , Dong Xu n , Jun Zhao o , Tian-An Jiang a , b , ∗; The Interventional Diagnosis and Treatment Group of the Ultrasonic Medicine Branch of Chinese Medical Association, The Nanoknife Tumor Ablation Society of the Interventional Minimally Invasive Therapy Special Committee of China Medicine Education Association |
a Department of Ultrasound Medicine, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
b Key Laboratory of Pulsed Power Translational Medicine of Zhejiang Province, Hangzhou, Zhejiang 310003, China
c Department of Radiology, The First Medical Center, Chinese PLA General Hospital, Beijing 100000, China
d Department of Radiology, The Fifth Medical Center, Chinese PLA General Hospital, Beijing 100853, China
e Department of Interventional Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
f Department of Interventional Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China
g Department of the Interventional Medical Center, the Affiliated Hospital of Qingdao University, Qingdao 266000, China
h Division of Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China
i Department of Oncology, Affiliated Fuda Cancer Hospital, Jinan University, Guangzhou 510665, China
j School of Electrical Engineering, Chongqing University, Chongqing 400033, China
k Department of Anesthesiology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China
l Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou
510080, China
m Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
n Department of Interventional Ultrasound, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of
Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou 310022, China
o Department of Anatomy, School of Basic Medicine, Huazhong University of Science and Technology, Wuhan 430030, China
∗ Corresponding author at: Department of Ultrasound Medicine, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.
E-mail address: tiananjiang@zju.edu.cn (T.-A. Jiang). |
|
|
Abstract Liver cancer remains a global health challenge, and its incidence is increasing worldwide. It is estimated that by 2025, more than one million individuals will be affected by liver cancer annually [1,2]. In recent years, ablation has become a widely accepted treatment option for patients with primary and secondary liver malignancies [3]. The commonly used ablation method for liver cancer is thermal ablation, including radiofrequency ablation, microwave ablation, laser ablation and cryoablation. However, many tumors cannot be treated with thermal ablation owing to hazardous tumor location. Thermal ablation of tumors adjacent to large blood vessels is associated with a higher incidence of incomplete eradication (heat-sink effect). In addition, these modalities can cause thermal injury to important structures such as bile ducts or intestines in the vicinity of the ablated area and can therefore be contraindicated [4,5].
|
|
|
|
|
|
|
|